Tag Archives: Regulatory Reform

TGA advertising system concerns: response from TGA

For background see: http://www.medreach.com.au/?p=2778 From: SKERRITT, John <John.Skerritt@health.gov.au> Sent: Tuesday, 18 September 2018 21:13 To: ken.harvey@medreach.com.au Cc: MCLAY, Nicole <Nicole.McLay@health.gov.au>; FRANCIS, Jenny <Jenny.Francis@health.gov.au>; SKERRITT, John <John.Skerritt@health.gov.au> Subject: RE: Letter from ACCC – TGA advertising concerns [SEC=UNCLASSIFIED] Dear Dr Harvey Thank you … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , | Leave a comment

Complaint to Commonwealth Ombudsman – TGA advertising complaint system

From 1 July 2018, the Therapeutic Goods Administration took over the complaint system for the advertising therapeutic goods to the public from the Complaint Resolution Panel (CRP). Many concerns about this TGA takeover were submitted in consultation submissions. They were … Continue reading

Posted in Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment

Launch of TGA Advertising Hub – Initial experience of submitting complaints

The TGA Advertising hub has noted: “We are experiencing intermittent IT issues that are impacting this form. If you experience an error lodging a complaint, please try again later. We are working to fix this issue as a matter of … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

TGA’s new complaint system fails the Ease-a-cold test; Outcomes of Advertising Complaints Investigations Specification 2018 enacted

Stimulated by an article in today’s “The Conversation” on Pharmacare Laboratories Ease-a-Cold (below), I decided to try the TGA’s new complaint system.As I mentioned in a comment on this article, this product has been the subject of a previous article … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment

TGA Advertising Portal and Complaint System now live; Industry embrace permissible indications

See: https://www.tga.gov.au/advertising-hub and: https://ajp.com.au/news/tga-explains-new-advertising-landscape/ However, there are still concerns about the transparency of the new system and my colleagues and I are holding off submitting complaints until we know: The outcome of the TGA Consultation: Complaints handling – Advertising therapeutic goods to … Continue reading

Posted in Complementary medicine, Medicine policy, Pharmaceutical Promotion | Tagged , , , | Leave a comment

TGA response to criticism of new complaint handling system; my comment

See: https://www.theguardian.com/australia-news/2018/jun/05/consumers-wont-know-about-dodgy-drug-ads-under-new-complaints-system-experts-warn The TGA media spokesperson said: “The new system will be more transparent than the previous one, apart from publication of TGA’s performance against key performance indicators detailed information on individual complaints will be published for medium-, serious- and critical-level … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment

Campaign to disallow the Therapeutic Goods (Permissible Indications) Determination No.1 of 2018

The Therapeutic Goods (Permissible Indications) Determination No.1 of 2018 is currently on the Senate Disallowable Instruments List until 25 June 2018. Friends of Science in Medicine (FSM) have joined Choice (the Australian Consumers’ Association) and other civil society organisations to petition … Continue reading

Posted in Complementary medicine, Education, Medicine policy | Tagged , , , , , , , , | Leave a comment

TGA Consultation: Complaint handling and monitoring

Yet another TGA consultation; this one closing on 4 June 2018 for a new regulatory system that is meant to start on 1 July 2018! For the last one on the draft new Therapeutic Goods Advertising Code, see my comments … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , , , , | Leave a comment

Therapeutic Goods Amendment Bill 2017 passed by Senate

This Bill was passed this morning (15/02/2018) by the Senate with the Labor supporting a Government amendment to continue advertising pre-approval (in mainstream media) for 2 years with a review after 18 months. The Government and Labor did not support … Continue reading

Posted in Complementary medicine, Medicine policy, Natural Therapies, Pharmaceutical Promotion, Senate | Tagged , , , , , , , | 1 Comment

More Publicity on the Therapeutic Goods Amendment Bill 2017

‘Softens hardness’: TGA under fire for health claim list that critics say endorses pseudoscience New list of permitted advertising lines for complementary medicine products does little to protect consumers ‘The Project’ (09/02/2018)  also had a hilarious segment on TGA traditional indication craziness. … Continue reading

Posted in Complementary medicine, Medicine policy, Natural Therapies, Pharmaceutical Promotion, Senate | Tagged , , , , | Leave a comment